The polymyxin resistance testing market is anticipated to be valued US$ 122.0 million in 2023. Over the course of the forecast period, the market is anticipated to grow at a 6.2% CAGR and reach US$ 222.5 million by 2033. A class of antibiotics known as polymyxins is used to treat serious infections brought on by Gram-negative bacteria …